Status:

WITHDRAWN

Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain

Lead Sponsor:

Vital 5, LLC

Conditions:

Low Back Pain

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the clinical performance of the ReLeaf infusion catheter \& wound drain in patients following lumbar spinal fusion surgery. One half of the patients will recei...

Detailed Description

Posterior lumbar spinal fusion is commonly used in the management of a wide array of spinal disorders ranging from instability to degenerative disc disease. However, severe postoperative pain is a sig...

Eligibility Criteria

Inclusion

  • Skeletally mature
  • Diagnosis of lumbar spine disease requiring an open, midline, instrumented posterolateral fusion with or without interbody support at one or two vertebral levels and laminectomy or laminotomy
  • Physically and mentally willing to comply with the study requirements
  • Signed the study informed consent

Exclusion

  • Lumbar spine disease requiring more than two levels of instrumentation
  • Any previous operative lumbar procedure, except discectomy or hemi-laminotomy performed a minimum of 2 years prior to current study surgery
  • Patients requiring iliac crest bone graft for the procedure
  • Intra-operative durotomy
  • Any duration of pre-operative morphine or morphine equivalent use exceeding 30 mg of morphine equivalents per day for longer than 3 months
  • Physically or mentally compromised (i.e., being currently treated for a psychiatric disorder, senile dementia, Alzheimer's disease, presence of alcohol or substance abuse)
  • Diagnosed with Severe Depression and on treatment
  • Active infection at the operative level or a symptomatic infection
  • Diagnosed systemic disease that would affect the subject's welfare or overall outcome of the research study (i.e. Paget's disease, renal osteodystrophy, Lupus etc)
  • Is pregnant or breast feeding
  • Has any active malignancy or spinal arthrodesis being performed for a tumor decompression
  • Has a known allergy to local analgesics
  • Pending litigation related to back pain or injury or Worker's Compensation

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2016

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02293525

End Date

January 1 2016

Last Update

January 22 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.